MVM IV (2019) LP
MVM Life Science Partners · adviser of record: MVM Partners LLP · 2019 vintage
MVM IV (2019) LP is a 2019 venture fund managed by MVM Life Science Partners, with $1mm raised (Form D, amount sold). It reported $2.2mm in gross assets at year-end 2025, 2.17x its size, against a peak of $11.5mm in 2022.
- Latest value held
- $2.2mm year-end 2025
- Peak
- $11.5mm year-end 2022
- Fund size
- $1mm Form D, amount sold
- Held vs. size
- 2.17x peak 11.31x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $2.2mm | 2.17x | -79% over 2 yrs |
| 2023 | $10.4mm | 10.22x | -10% |
| 2022 | $11.5mm | 11.31x | +6% |
| 2021 | $10.8mm | 10.63x | +107% |
| 2020 | $5.2mm | 5.14x | – |
Other funds from MVM Life Science Partners
- MVM IV CO-Investment I LP 2014
- MVM IV LP 2013
- MVM Fund III Limited Partnership 2011
- MVM International Life Sciences No.1 Limited Partnership 2011
- UK Medical Ventures Fund No. 1 Limited Partnership 2011
- MVM Fund III (No.2) Limited Partnership 2011
All MVM Life Science Partners funds
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-8344360053. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.